Sökning: "chronic kidney disease"

Visar resultat 21 - 25 av 183 avhandlingar innehållade orden chronic kidney disease.

  1. 21. Analysis of risk factors in patients with severe chronic kidney disease. The role of atorvastatin

    Författare :Benny Holmberg; Bernd G Stegmayr; Christer Andersson; Peter M Nilsson; Umeå universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Atorvastatin; cholesterol; chronic kidney disease; haemodialysis; cholesterol; lipids; peritoneal dialysis; risk factors; statins; inter dialysis weight gain;

    Sammanfattning : Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular end-points and the overall mortality rate of patients with chronic kidney disease stage 4 or 5 (creatinine clearanceMaterial & Methods: This was an open, prospective, randomized study. LÄS MER

  2. 22. The role of fibroblast growth factor-23 in chronic kidney disease-mineral and bone disorder

    Författare :Majd A. I. Mirza; Tobias Larsson; Tilman Drüeke; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; FGF23; FGF-23; CKD; CKD-MBD; cardiovascular disease; vascular function; atherosclerosis; hypertrophy; LVMI; LVH; fractures; bone; fat mass; obesity; apolipoproteins; cholesterol; lipids; Kidney diseases; Njursjukdomar; Cardiovascular medicine; Kardiovaskulär medicin; Medicinsk vetenskap; Medical Science;

    Sammanfattning : Fibroblast growth factor-23 (FGF23) was initially identified as the causative factor of autosomal dominant hypophosphatemic rickets. Further studies confirmed that FGF23 is predominantly expressed in the osteocytes and osteoblasts of bone and that circulating FGF23 acts on the kidney to inhibit renal phosphate reabsorption and 1,25(OH)2D3 hydroxylation. LÄS MER

  3. 23. Body composition, arteriosclerosis and exercise training in patients with chronic kidney disease

    Författare :Yunan Zhou; Njurmedicin; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Chronic kidney disease CKD ; exercise training; muscle mass; Sarcopenia; arteriosclerosis; Abdominal aortic calcification AAC ; myostatin; Lipids; lipoproteins; Fibroblast growth factor 23; fetuin-A; Interleukin 6;

    Sammanfattning : .... LÄS MER

  4. 24. Bone alkaline phosphatase isoforms in chronic kidney disease : mineral and bone disorder

    Författare :Mathias Haarhaus; Per Magnusson; Anders Fernström; Bengt Lindholm; Goce Spasovski; Linköpings universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Sammanfattning : Chronic kidney disease (CKD) is associated with increased mortality and cardiovascular complications. Disturbances in mineral metabolism occur early In study I we identified the novel BALP isoform Blx in 20% of patients with mild to moderate CKD. LÄS MER

  5. 25. Oral health in patients with chronic kidney disease

    Författare :Royne Thorman; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Chronic kidney disease (CKD) is a complex disorder in which active intervention leads to longer survival expectancy. Oral diseases are complex disorders caused mainly by bacterial, fungal, or viral infections, where primary defense mechanisms are influenced. LÄS MER